Zobrazeno 1 - 10
of 47
pro vyhledávání: '"predictive response"'
Publikováno v:
World Journal of Gastrointestinal Oncology
Gastrointestinal (GI) cancers account for a large proportion of cancer deaths worldwide and pose a major public health challenge. Immunotherapy is considered to be one of the prominent and successful approaches in cancer treatment in recent years. Am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0279434a14d87f6888f7e1593603a7fd
https://doi.org/10.4251/wjgo.v14.i1.19
https://doi.org/10.4251/wjgo.v14.i1.19
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carlos del Pozo, Gabriel Obiols, Raquel Buj, Laura Pons, Joan Gil, Isabel Salinas, Alberto Blanco, Carmen Fajardo-Montañana, Montserrat Marques-Pamies, Miguel Sampedro-Núñez, Susan M. Webb, Manel Puig-Domingo, Mónica Marazuela, Clara V. Alvarez, Guillermo Serra, Antonio Picó, Rosa Cámara, Carles Villabona, Ignacio Bernabeu, Elena Valassi, Mireia Jordà, Cristina Carrato, Araceli García-Martínez
Publikováno v:
Endocrine-Related Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Pharmacologic treatment of acromegaly is currently based upon assay-error strategy, the first-generation somatostatin receptor ligands (SRL) being the first-line treatment. However, about 50% of patients do not respond adequately to SRL. Our objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e6b6f6d0d0f6695db5a5520207339b
https://doi.org/10.1530/erc-18-0565
https://doi.org/10.1530/erc-18-0565
Autor:
Camille Mazza, Vincent Gaydou, Jean-Christophe Eymard, Philippe Birembaut, Valérie Untereiner, Jean-François Côté, Isabelle Brocheriou, David Coeffic, Philippe Villena, Stéphane Larré, Vincent Vuiblet, Olivier Piot
Publikováno v:
Cancers
Cancers, Vol 14, Iss 21, p 21 (2022)
Cancers, Vol 14, Iss 21, p 21 (2022)
Simple Summary Assessing the tumor response to chemotherapy is a paramount predictive step to improve patient care. Infrared spectroscopy probes the chemical composition of samples, and in combination with statistical multivariate processing, present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::55d6a19b0c3b1bc55385f7d155d37cab
http://europepmc.org/articles/PMC8750189
http://europepmc.org/articles/PMC8750189
Autor:
Roubini Zakopoulou, Aristotelis Bamias, Marie Auvray, Philippe Camparo, Xavier Barthere, Mostefa Bennamoun, Daniela Bruni, Pierre Colin, Isabelle Boquet, Jérôme Galon, Gabriela Bindea, Elise F. Nassif, François Audenet, Virginie Verkarre, Bernhard Mlecnik, Alexandre Colau, Bruno d’Acremont, Aurelie Catteau, Stéphane Oudard, Marine Martel, Marine Lefevre, Arnaud Mejean, Eva Comperat, Aurelie Fugon, Constance Thibault
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (3), pp.494. ⟨10.3390/cancers13030494⟩
Volume 13
Issue 3
Cancers, Vol 13, Iss 494, p 494 (2021)
Cancers, MDPI, 2021, 13 (3), pp.494. ⟨10.3390/cancers13030494⟩
Volume 13
Issue 3
Cancers, Vol 13, Iss 494, p 494 (2021)
(1) Background&mdash
The five-year overall survival (OS) of muscle-invasive bladder cancer (MIBC) with neoadjuvant chemotherapy and cystectomy is around 50%. There is no validated biomarker to guide the treatment decision. We investigated whethe
The five-year overall survival (OS) of muscle-invasive bladder cancer (MIBC) with neoadjuvant chemotherapy and cystectomy is around 50%. There is no validated biomarker to guide the treatment decision. We investigated whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65fa3039bd201fa65a8e309e9d69ea78
https://hal.sorbonne-universite.fr/hal-03154109/document
https://hal.sorbonne-universite.fr/hal-03154109/document
Autor:
Carine El Sissy, Amos Kirilovsky, Guy Zeitoun, Florence Marliot, Nacilla Haicheur, Christine Lagorce-Pagès, Jérôme Galon, Franck Pagès
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (6), pp.1281. ⟨10.3390/cancers13061281⟩
Cancers, 2021, 13 (6), pp.1281. ⟨10.3390/cancers13061281⟩
Cancers, Vol 13, Iss 1281, p 1281 (2021)
Cancers, MDPI, 2021, 13 (6), pp.1281. ⟨10.3390/cancers13061281⟩
Cancers, 2021, 13 (6), pp.1281. ⟨10.3390/cancers13061281⟩
Cancers, Vol 13, Iss 1281, p 1281 (2021)
Simple Summary Beyond the TNM-staging system, biomarkers are needed to guide cancer treatments. We provide an overview of the Immunoscore, a standardized immune assay based on quantification by digital pathology of CD3+ and CD8+ cytotoxic T cells in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0c4397a51dbacececb2fe90a3efca4cc
https://hal.sorbonne-universite.fr/hal-03190246/file/cancers-13-01281-v2.pdf
https://hal.sorbonne-universite.fr/hal-03190246/file/cancers-13-01281-v2.pdf
Autor:
Mariasole Perrone, Andrea Bonetti, R Taibi, Sonia Missiroli, Francesco Fiorica, Jacopo Giuliani, Maria Colella, Carlotta Giorgi
Publikováno v:
Current medicinal chemistry. 27(17)
Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. : Here we try to summarize the main clinical and biol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1232bb109c1106f560add85aa915b18
https://pubmed.ncbi.nlm.nih.gov/32003678
https://pubmed.ncbi.nlm.nih.gov/32003678
Autor:
Puig-Domingo M, Gil J, Sampedro-Nunez M, Jorda M, Webb S, Serra G, Pons L, Salinas I, Blanco A, Marques-Pamies M, Valassi E, Pico A, Garcia-Martinez A, Carrato C, Buj R, del Pozo C, Obiols G, Villabona C, Camara R, Fajardo-Montanana C, Alvarez C, Bernabeu I, Marazuela M, REMAH Investigators
Publikováno v:
ENDOCRINE-RELATED CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Pharmacologic treatment of acromegaly is currently based upon assay-error strategy, the first-generation somatostatin receptor ligands (SRL) being the first-line treatment. However, about 50% of patients do not respond adequately to SRL. Our objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0363bded39520925dff92eef6f4cb5d0
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2014
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2014
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.